Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 5 Issue 1

Early Therapeutic Intervention in COVID-19 Infection May Prevent Death

Tapan K Chaudhuri* and Richard Hoffler

Hampton, VA and San Antonio, TX, USA.

*Corresponding Author: Tapan K Chaudhuri, Hampton, VA, USA. E-mail: tkchaudhuri44@gmail.com

Received: December 07, 2020; Published: December 22, 2020

×

  It appears that COVID-19 infection (SARS-CoV-2) has two distinct clinical phases - Early Nasopharyngial phase and Late Bronchoalveolar Phase.

×

References

×

Citation

Citation: Tapan K Chaudhuri and Richard Hoffler. “Early Therapeutic Intervention in COVID-19 Infection May Prevent Death". Acta Scientific Pharmaceutical Sciences 5.1 (2021): 94.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days
Impact Factor1.020

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US